Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice

Journal of Clinical Investigation

Volumn 109, Issue 3, 2002, Pages 383-392

  Graesser, Donnasue ^a   Solowiej, Anna ^a   Bruckner, Monika ^b   Osterweil, Emily ^a   Juedes, Amy ^a   Davis, Sandra ^a   Ruddle, Nancy H ^a   Engelhardt, Britta ^b   Madri, Joseph A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN; HISTAMINE; IMMUNOGLOBULIN; MEMBRANE PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; CELL CULTURE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; KNOCKOUT MOUSE; LEUKOCYTE; LYMPHOCYTE MIGRATION; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THROMBOCYTE;

EID: 0036167828     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213595     Document Type: Article

References (56)

1. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily
2. A human endothelial cell-restricted, externally disposed plasmolemmal protein enriched in intercellular junctions
3. EndoCAM: A novel endothelial cell-cell adhesion molecule
4. A novel leukocyte differentiation antigen: Two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts
5. Biochemistry and expression of myelomonocytic antigens
6. Molecular characterization and functional analysis of the leukocyte surface protein CD31
7. Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RA-) CD4-positive T cells
8. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule
9. Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1
10. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts
11. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule-1
12. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves surface glycosaminoglycans
13. PECAM-1 is required for transendothelial migration of leukocytes
14. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1
15. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1/CD31) in natural killer cell transendothelial cell migration and beta2 integrin activation
16. Involvement of platelet/endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo
17. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo
18. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane
19. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1 dependent homophilic adhesion block in vivo neutrophil recruitment
20. Studies of lymphocyte transendothelial migration: Analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO
21. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions
22. Activation-dependent changes in human platelet PECAM-1 phosphorylation, cytoskeletal association, and surface membrane redistribution
23. The cell adhesion molecule CD31 is phosphorylated after cell activation
24. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1
25. Aggregation of high affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31)
26. Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells
27. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation
28. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31)
29. PECAM-1 (CD31) functions as a reservoir and modulator of tyrosine-phosphorylated β-catenin
30. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties
31. CD31 expressed on distinctive T cell subsets is a preferential amplifier of B1 integrin-mediated adhesion
32. Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta2 integrins on lymphokine-activated killer cells
33. CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells
34. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils
35. Integrins: Versatility, modulation, and signaling in cell adhesion
36. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction
37. Inhibition of antigen-receptor signaling by platelet-endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56ck
38. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
39. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat
40. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
41. Organ-specific change in Dolichos biflorus lectin binding by myocardial endothelial cells during in vitro cultivation
42. Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro
43. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin
44. T cell interaction with ICAM-1 deficient endothelium in vitro: Requisite role for ICAM-1 and ICAM-2 in transendothelial migration of T cells
45. PECAM-1/CD31 trans-homophilic binding the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin αvβ3 in cis
46. Advanced mammalian gene transfer high titer retroviral vectors with multiple drug selection markers and a complementary help-free packaging cell line
47. PECAM-1 (CD31) expression modulates bleeding time in vivo
48. The inter-relationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis
49. Distinct roles for matrix metalloproteinase-1 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis
50. Reversal of experimental autoimmune encephalomyelitis with a hydroxymate inhibitor of matrix metalloproteinases
51. Selective requirement for src kinases during VEGF-induced angiogenesis and vascular permeability
52. Vasoactive agents modulate migration of monocytes across glomerular endothelial cells
53. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells
54. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin
55. The molecular basis for the assembly and modulation of adherens-type junctions
56. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells